Oramed Pharmaceuticals Inc.
ORMP
$2.75
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 37.52% | -25.03% | -7.95% | -0.26% | -6.83% |
| Total Receivables | -34.21% | 193.75% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 116.42% | -23.88% | -51.67% | 172.36% | -11.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.46% | -24.68% | -8.20% | 0.31% | -6.85% |
|
|
|||||
| Total Current Assets | 37.46% | -24.68% | -8.20% | 0.31% | -6.85% |
| Net Property, Plant & Equipment | -6.29% | 50.74% | -8.90% | -7.64% | -9.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -75.97% | -18.12% | 16,135.29% | 6.25% | 6.67% |
| Total Assets | 36.37% | 9.59% | -4.98% | -5.94% | -10.39% |
|
|
|||||
| Total Accounts Payable | -21.68% | 40.47% | -35.49% | -84.20% | 43.41% |
| Total Accrued Expenses | -27.78% | 11.83% | -31.30% | 4,117.14% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.65% | 45.86% | -16.20% | -11.11% | -2.80% |
| Total Finance Division Other Current Liabilities | 182.85% | -58.29% | 18.23% | -- | -- |
| Total Other Current Liabilities | 182.85% | -58.29% | 18.23% | -- | -- |
| Total Current Liabilities | 65.69% | -32.76% | -3.39% | 7.81% | 41.25% |
|
|
|||||
| Total Current Liabilities | 65.69% | -32.76% | -3.39% | 7.81% | 41.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.10% | 440.00% | -23.08% | -16.13% | -21.19% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 204.65% | 84.95% | -50.29% | -0.24% | 0.00% |
| Total Liabilities | 124.21% | 5.96% | -23.02% | 3.89% | 18.47% |
|
|
|||||
| Common Stock & APIC | 0.11% | 0.13% | 0.68% | 0.00% | -0.31% |
| Retained Earnings | 28.31% | 7.21% | -4.33% | -6.12% | -13.36% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 31.55% | 9.74% | -3.73% | -6.50% | -11.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.55% | 9.74% | -3.73% | -6.50% | -11.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -0.63% | -3.05% | 0.00% | 0.11% | -0.88% |
| Total Equity | 31.74% | 9.79% | -3.75% | -6.54% | -11.71% |
|
|
|||||